Clinical Trial: Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154108) titled 'Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer' on Aug. 27.

Brief Summary: This is a Phase I, open-label, dual-cohort clinical trial designed to evaluate the safety, tolerability, and preliminary efficacy of intratumoral injection of recombinant human endostatin adenovirus in combination with a PD-1 inhibitor in patients with recurrent or metastatic head and neck cancer, or in patients with esophageal squamous cell carcinoma (ESCC) with superficial lymph node metastasis.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Esophageal Cancer Head and Neck Cancer (H&Amp;A...